Study on the Correlation Between the CRP/HDL-C Ratio and All-Cause Mortality in NSTEMI Patients

Key Points

• This analysis aims to explore the relationship between the CRP/HDL-C ratio and all-cause mortality in NSTEMI patients.
• Conducted as a retrospective, single-center clinical observation involving 864 NSTEMI patients from January 2018 to December 2023.
• Patients were divided into low and high CRP/HDL-C groups according to the median ratio, with follow-up conducted until October 2024.
• Utilized multifactorial Cox regression analysis to determine factors influencing all-cause mortality.
• Low CRP/HDL-C group had a significantly lower all-cause mortality rate (12.11%) compared to the high CRP/HDL-C group (21.71%), P<0.05.
• Cox regression analysis identified age (HR=1.070, 95% CI: 1.047-1.093, P<0.001) and CRP/HDL-C ratio (HR=1.265, 95% CI: 1.037-1.542, P=0.020) as factors associated with all-cause mortality.
• High CRP/HDL-C ratio is a risk factor for increased mortality, but not an independent risk factor.